ArticleTH open : companion journal to thrombosis and haemostasis2024

Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors.

Mark Goldin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.